Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Myeloproliferative Disorder Drugs
The 2025-2030 World Outlook for Myeloproliferative Disorder Drugs This study covers the world outlook for myeloproliferative disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Respiratory Drugs
The 2025-2030 World Outlook for Respiratory Drugs This study covers the world outlook for respiratory drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for RNA Therapeutics
The 2025-2030 World Outlook for RNA Therapeutics This study covers the world outlook for RNA therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for RNA-Based Therapeutics
The 2025-2030 World Outlook for RNA-Based Therapeutics This study covers the world outlook for RNA-based therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Cardiovascular Therapeutics
The 2025-2030 World Outlook for Cardiovascular Therapeutics This study covers the world outlook for cardiovascular therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Epilepsy Therapeutics
The 2025-2030 World Outlook for Epilepsy Therapeutics This study covers the world outlook for epilepsy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Veterinary Therapeutics
The 2025-2030 World Outlook for Veterinary Therapeutics This study covers the world outlook for veterinary therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes This study covers the world outlook for intravenous immunoglobulin for guillain-Barre syndromes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Crohn's Disease Therapeutics
The 2025-2030 World Outlook for Crohn's Disease Therapeutics This study covers the world outlook for Crohn's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Dermatophytic Onychomycosis Therapeutics
The 2025-2030 World Outlook for Dermatophytic Onychomycosis Therapeutics This study covers the world outlook for dermatophytic onychomycosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for HIV Therapeutics
The 2025-2030 World Outlook for HIV Therapeutics This study covers the world outlook for HIV therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Cancer-Treating Drugs
The 2025-2030 World Outlook for Cancer-Treating Drugs This study covers the world outlook for cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Drugs
The 2025-2030 World Outlook for Liver Cancer Drugs This study covers the world outlook for liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments
The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments This study covers the world outlook for basal cell carcinoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Scleroderma Diagnostics and Therapeutics
The 2025-2030 World Outlook for Scleroderma Diagnostics and Therapeutics This study covers the world outlook for scleroderma diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma This study covers the world outlook for non-Hodgkin lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Sequencing and Target Data Analysis Drug Discovery Informatics
The 2025-2030 World Outlook for Sequencing and Target Data Analysis Drug Discovery Informatics This study covers the world outlook for sequencing and target data analysis drug discovery informatics across more than 190 countries. For each year reported, estimates are given for the latent demand, or ... Read More
-
The 2025-2030 World Outlook for Hypertrophic Cardiomyopathy Therapeutics
The 2025-2030 World Outlook for Hypertrophic Cardiomyopathy Therapeutics This study covers the world outlook for hypertrophic cardiomyopathy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Oncology Therapeutics
The 2025-2030 World Outlook for Oncology Therapeutics This study covers the world outlook for oncology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments This study covers the world outlook for non-Hodgkin lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms for Pharmaceutical Vendors
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms for Pharmaceutical Vendors This study covers the world outlook for cloud-based drug discovery platforms for pharmaceutical vendors across more than 190 countries. For each year reported, estimates are given for the latent demand, o ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Drugs
The 2025-2030 World Outlook for Neurodegenerative Drugs This study covers the world outlook for neurodegenerative drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Diabetes Therapeutics
The 2025-2030 World Outlook for Diabetes Therapeutics This study covers the world outlook for diabetes therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Diabetes Therapeutics and Diagnostics
The 2025-2030 World Outlook for Diabetes Therapeutics and Diagnostics This study covers the world outlook for diabetes therapeutics and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Sarcoma Drugs
The 2025-2030 World Outlook for Sarcoma Drugs This study covers the world outlook for sarcoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
Research Assistance
